DUSA Pharma: Court Prohibits Biofrontera From Using DUSA's Trade Secrets

(RTTNews) - DUSA Pharmaceuticals, Inc., a subsidiary of Sun Pharmaceutical Industries Ltd., announced the company has been granted preliminary injunctive relief by a federal district court prohibiting Biofrontera from using DUSA's confidential and proprietary trade secret information. DUSA had filed a lawsuit against the Biofrontera defendants earlier in the current year alleging trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering LEVULAN KERASTICK for topical solution, 20% used with BLU-U Blue Light Photodynamic Therapy Illuminator.

DUSA Pharma noted that the court has stated that "at this early stage, it would appear that DUSA has a reasonable prospect of success on the merits."